These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16599037)

  • 21. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Kavŭrdzhikova S
    Akush Ginekol (Sofiia); 2006; 45(6):29-35. PubMed ID: 17168480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.
    Oner G; Muderris II
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):127-31. PubMed ID: 21831508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome.
    Palomba S; Falbo A; Orio F; Tolino A; Zullo F
    Fertil Steril; 2009 Jun; 91(6):2557-67. PubMed ID: 18440534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
    Lord J; Thomas R; Fox B; Acharya U; Wilkin T
    BJOG; 2006 Jul; 113(7):817-24. PubMed ID: 16827766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovary syndrome in adolescents.
    Kent SC; Legro RS
    Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical effects of metformin in patients with polcystic ovarian syndrome].
    Galindo CG; Hernández I; Ayala AR
    Ginecol Obstet Mex; 2007 Apr; 75(4):181-6. PubMed ID: 17849796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
    Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
    Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
    J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
    Horng SG; Wang TH; Wang HS
    Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
    Fleming R; Harborne L; MacLaughlin DT; Ling D; Norman J; Sattar N; Seifer DB
    Fertil Steril; 2005 Jan; 83(1):130-6. PubMed ID: 15652898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin treatment is effective in obese teenage girls with PCOS.
    De Leo V; Musacchio MC; Morgante G; Piomboni P; Petraglia F
    Hum Reprod; 2006 Sep; 21(9):2252-6. PubMed ID: 16785260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
    Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does metformin induce ovulation in normoandrogenic anovulatory women?
    Carmina E; Lobo RA
    Am J Obstet Gynecol; 2004 Nov; 191(5):1580-4. PubMed ID: 15547527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperinsulinemia and disorders of the menstrual cycle].
    Dravecká I; Lazúrová I; Kraus V; Petrovicová J; Paĺko M
    Vnitr Lek; 2002 Mar; 48(3):192-6. PubMed ID: 11968579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD; Strucchi C; Luisi M; Casarosa E; Lanzoni C; Baraldi E; Ricchieri F; Mehmeti H; Genazzani AR
    Gynecol Endocrinol; 2006 Jan; 22(1):36-43. PubMed ID: 16522532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.